Go to
JCI Insight
Citations to this article
Jonathan Z. Li, Joel N. Blankson
Published June 1, 2021
Citation Information: J Clin Invest. 2021;131(11):e149414. https://doi.org/10.1172/JCI149414.
Citation Information: J Clin Invest. 2021;131(11):e149414. https://doi.org/10.1172/JCI149414.
Abstract
A small percentage of people living with HIV-1 can control viral replication without antiretroviral therapy (ART). These patients are called elite controllers (ECs) if they are able to maintain viral suppression without initiating ART and posttreatment controllers (PTCs) if they control HIV replication after ART has been discontinued. Both types of controllers may serve as a model of a functional cure for HIV-1 but the mechanisms responsible for viral control have not been fully elucidated. In this review, we highlight key lessons that have been learned so far in the study of ECs and PTCs and their implications for HIV cure research.
Authors
Jonathan Z. Li, Joel N. Blankson
Citation information
Citations to this article (27)
| Title and authors | Publication | Year |
|---|---|---|
|
HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation
Tyers L, Moeser M, Ntuli J, Council O, Zhou S, Spielvogel E, Sondgeroth A, Adams C, Thebus R, Yssel A, Karim SA, Garrett N, Pond SK, Williamson C, Swanstrom R, Abrahams MR, Joseph SB |
bioRxiv | 2025 |
|
HIV controllers: hope for a functional cure
Deng Z, Yan H, Lambotte O, Moog C, Su B |
Frontiers in Immunology | 2025 |
|
The utility of nonhuman primate models for understanding acute HIV-1 infection
Parsons MS, Bolton DL |
Current Opinion in HIV and AIDS | 2025 |
|
Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection
Tiemessen CT |
Current Opinion in HIV and AIDS | 2025 |
|
The Complex Interactions Between HIV-1 and Human Host Cell Genome: From Molecular Mechanisms to Clinical Practice
Tolomeo M, Tolomeo F, Cascio A |
International Journal of Molecular Sciences | 2025 |
|
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV.
Bowden-Reid E, Moles E, Kelleher A, Ahlenstiel C |
Drug delivery and translational research | 2025 |
|
New latency-promoting agents for a block-and-lock functional cure strategy.
Pellaers E, Denis A, Debyser Z |
Current Opinion in HIV and AIDS | 2024 |
|
Advanced HIV disease in East Africa and Nigeria, in The African Cohort Study
Oboho IK, Esber AL, Dear N, Paulin HN, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Shah N, Crowell TA, Ake JA, Polyak CS |
Journal of acquired immune deficiency syndromes (1999) | 2024 |
|
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod
Abdel-Mohsen M, Deeks S, Giron L, Hong KY, Goldman A, Zhang L, Huang SS, Verrill D, Guo S, Selzer L, de Vries CR, Vendrame E, SenGupta D, Wallin JJ, Cai Y |
Frontiers in immunology | 2024 |
|
The Impact of Sex on HIV Immunopathogenesis and Therapeutic Interventions
Erin Mihealsick, Anna Word, Eileen P. Scully |
Journal of Clinical Investigation | 2024 |
|
Modelling HIV-1 control and remission.
Vemparala B, Chowdhury S, Guedj J, Dixit NM |
npj Systems Biology and Applications | 2024 |
|
Survival Analysis and Immune Differences of HIV Long-Term Non-progressors in Xinjiang China: A 12-Year Prospective Cohort Observation.
Li Y, Ni Y, He Q, Hu X, Zhang Y, He X, Ni M |
AIDS and behavior | 2024 |
|
In-depth characterization of full-length archived viral genomes after nine years of posttreatment HIV control
Pauline Trémeaux, Frédéric Lemoine, Adeline Mélard, Marine Gousset, Faroudy Boufassa, Sylvie Orr, Valérie Monceaux, Olivier Gascuel, Olivier Lambotte, Laurent Hocqueloux, Asier Saez-Cirion, Christine Rouzioux, Véronique Avettand-Fenoel |
Microbiology spectrum | 2023 |
|
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques
Harwood OE, Matschke LM, Moriarty RV, Balgeman AJ, Weaver AJ, Ellis-Connell AL, Weiler AM, Winchester LC, Fletcher CV, Friedrich TC, Keele BF, O\u2019Connor DH, Lang JD, Reynolds MR, O\u2019Connor SL |
2023 | |
|
Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones
Filippo Dragoni, Abena Kwaa, Caroline Garliss, Rebecca Veenhuis, Bezawit Woldemeskel, Angelica Camilo-Contreras, Haley Raymond, Arbor Dykema, Eileen Scully, Amanda Rosecrans, Kellie Smith, Frederic Bushman, Francesco Simonetti, Joel Blankson |
Journal of Clinical Investigation | 2023 |
|
Recent advances in CD8+ T cell-based immune therapies for HIV cure
Arenas VR, Rugeles MT, Perdomo-Celis F, Taborda N |
Heliyon | 2023 |
|
HIV infection.
Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV |
Nature Reviews Disease Primers | 2023 |
|
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection
Harwood OE, Matschke LM, Moriarty RV, Balgeman AJ, Weaver AJ, Ellis-Connell AL, Weiler AM, Winchester LC, Fletcher CV, Friedrich TC, Keele BF, O\u2019Connor DH, Lang JD, Reynolds MR, O\u2019Connor SL |
PLoS pathogens | 2023 |
|
HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies
E Kreider, K Bar |
Current HIV/AIDS Reports | 2022 |
|
Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches
Moran JA, Turner SR, Marsden MD |
Frontiers in immunology | 2022 |
|
NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses
Mensching L, Hoelzemer A |
Frontiers in immunology | 2022 |
|
Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa.
Ahmed RA, Adekoya KO, Onwuamah CK, Oboh BO, Iyer SS, Oluwatosin AS, Audu RA, Ezechi OC |
Viruses | 2022 |
|
CD8 + T-cell responses in HIV controllers: potential implications for novel HIV remission strategies.
Rutishauser RL, Trautmann L |
Current Opinion in HIV and AIDS | 2022 |
|
Combination strategies to durably suppress HIV-1: Soluble T cell receptors.
Wallace Z, Singh PK, Dorrell L |
Journal of virus eradication | 2022 |
|
Selective miRNA inhibition in CD8+ cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses
Madrid-Elena N, Serrano-Villar S, Gutiérrez C, Sastre B, Morín M, Luna L, Martín L, Santoyo-López J, López-Huertas MR, Moreno E, García-Bermejo ML, Moreno-Pelayo MÁ, Moreno S |
Frontiers in immunology | 2022 |
|
Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models.
Brombin C, Bagaglio S, Cugnata F, Castagna A, Uberti-Foppa C, Salpietro S, Di Serio C, Morsica G |
Scientific Reports | 2022 |
|
Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays
Khetan P, Liu Y, Dhummakupt A, Persaud D |
Viruses | 2022 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)